ArticleExperimental and therapeutic medicine2020

Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.

Daye Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.